Methods of Extracorporeal Immunopharmacotherapy: From General Medical Clinical Practice to Oncologic Practice (Literature Review)

Authors

  • Mirzagoleb N. Tillyashaikhov Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology Author
  • Sergey V. Kamishov Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology Author
  • Mahsuda A. Tillyashaikhova The Uzbekistan State Institute of Arts and Culture Author

DOI:

https://doi.org/10.61841/abz07d50

Keywords:

Malignant Tumors, Plasmapheresis, Cervical Cancer (CC), Extracorporeal Immunopharmacotherapy (EIPhT)

Abstract

The review presents the results of the application of extracorporeal immunopharmacotherapy (EIFT) techniques in medical practice for the treatment of infectious and autoimmune diseases, as well as septic complications. EIFT studies as an accompanying therapy in the treatment of malignant tumors are presented. The widespread practical implementation of EIFT is hindered by inadequate clinical testing for various diseases, a small spectrum of studied drugs, and the lack of adequate methods for predicting efficacy. In our own studies on the example of patients with cervical cancer of the II-III stages, it was shown that the immunotherapy regimen is most effective in complex treatment, including intermittent plasmapheresis followed by EIFT, which improves blood counts, increases leuko- and lymphopoiesis, normalizes cellular and humoral immunity, reduces the main clinical manifestations of chemotherapy toxicity, improves indicators of the subjective state of patients and their quality of life, and also allows you to increase indicators of the five-year survival rate. 

Downloads

Download data is not yet available.

References

[1] Alimkhodzhaeva L.T. Cycloferon and extracorporeal therapy in optimization of neoadjuvant PCT of

locally advanced breast cancer // Medical Journal of Uzbekistan. 2007;1:54-57.

[2] Antoneeva I.I. Immunopathology and immunotherapy of ovarian cancer. Monograph. -Ulyanovsk,

2007; 143 p.

[3] Ausheva T.V. Autohemochemotherapy in combination with extracorporeal magnetic blood processing in

The complex treatment of malignant bone tumors: diss... cand.med. sciences. - Rostov-on-Don, 2005.

[4] Voinov V.A. Tactics of efferent therapy in sepsis // Bulletin of Surgery named after I.I. Grekov. 2013;2:75-

78.

[5] Gushchin N.S., Leskov V.P., Prozorovsky N.S. Experimental substantiation of extracorporeal

immunopharmacotherapy // Actual issues of immunopharmacotherapy. Moscow, 1987. P. 71-82.

[6] Zharinov G.M., Molchanov O.E., Agafonova M.V., Rumyantseva S.Yu. The first experience of the local

Immunotherapy of oncogynecological patients // Cytokines and inflammation. 2002. V.1. –№2. –P.75.

[7] Zinchenko S.V. Immunomodulators in the treatment of cancer patients (literature review) // Volga

Oncology Bulletin. 2014;1:57-64.

[8] Kamyshov S.V., Pulatov D.A., Nishanov D.A., Yuldasheva N.Sh.

[9] The effect of the expression level of tumor markers on the results of treatment of patients with cervical

cancer who received accompanying immunotherapy // Evraz. oncologist. magazine. 2017; 1:68-76.

[10] Kamyshov S.V., Pulatov D.A., Yuldasheva N.Sh. Study of the role of extracorporeal

immunopharmacotherapy in reducing the toxic effects of chemoradiotherapy in patients with cervical

cancer //Evraz. oncologist. magazine. 2015;4. –V,7. –P.28-34.

[11] Kiseleva E.A., Volkova S.D., Chechetkin A.V. The development of methods of gravitational blood surgery

in a specialized medical institution // Herald of the Blood Service of Russia. 2016; 3:10-14.

[12] Clinical use of extracorporeal treatment methods / Ed. N.N. Kalinin. - Moscow: Trekpor Technology,

2006.168 p.

[13] Korotky N.G., Ujuhu V.Yu., Flaks G.A. The first experience of using cytapheresis with extracorporeal therapy with leukinferon in patients with psoriasis // Russian Journal of Skin and Sexually Transmitted Diseases. 1998;3:36-38.

[14] Kostyuchenko A.L. Efferent therapy. - St. Petersburg: Foliant, 2000. –432 p.

[15] Leskov V.P., Gushchin I.S. Extracorporeal immunopharmacotherapy // Pulmonology. 1994;4:10-14.

[16] Mendelenko M.M., Kravchenko I.N., Agadzhanyan K.V., Kravchenko A.I. Obtaining cytokines from blood

leukocytes activated by cycloferon // Ross. Immunologist. Magazine. 2001;6. V.4. –P.377-382.

[17] Nikogosyan S.O., Kuznetsov V.V. Ovarian cancer: diagnostic issues and modern treatment methods //Doctor. 2010;9:2-9.

[18] Popovich A.M. Immunotherapy in oncology. Handbook on immunotherapy for a practitioner. -SPb:

Dialog, 2002, pp. 335-352.

[19] Romanes M.A. Extracorporeal immunopharmacotherapy of psoriasis patients: diss... cand. med. sciences. –

Moscow, 2010.

[20] Snezhko T.A. Extracorporeal immunotherapy in the complex treatment of patients with relapses and

Refractory Hodgkin's lymphoma: diss... cand. med. sciences. Rostov-on-Don—2015.

[21] Sumina D.S. Clinical and immunological efficacy of extracorporeal immunopharmacotherapy in the

Complex treatment of psoriasis: author. dis. Cand. med. -Kursk, 2009.—24 p.

[22] Yudina S.M. Extracorporeal immunopharmacotherapy of patients with sepsis and severe purulent infection

// Bulletin of Intensive Therapy. 1995;2:44-48.

[23] Yarustovsky MB, Abrahamyan MV, Krotenko NP, Komardina EV. Methods of molecular transfusiology in

intensive care of critical conditions // RAMS. 2016;4:13-19.

[24] Bambauer R., Latzo R., Schiel R. Therapeutic plasma exchange and selective plasma separation methods.

Fundamental technologies, pathology, and clinical results. Pabst Science Publishers, Lengerich/Berlin,

2013.—P. 395–402.

[25] Bhardwaj N. Harnessing the immune system to treat cancer // J. Clin. Invest. 2007. –V.117. –P.1130–1136.

[26] DiSaia P.J., Creasman W.T. (eds.). Clinical gynecologic oncology.—7th - Mosby Elsevier, 2007. -- 812

p.

[27] Gattinoni L., Powell D.J., Rosenberg S.A., Restifo N.P. Adoptive immunotherapy for cancer: building on

success // Nat. Rev. Immunol. - 2006. - N6. - P. 383–393.

[28] Gavrusev A., Strotsky A., Malashchitsky D. Extracorporeal magnetic therapy for the treatment of chronic

prostatitis // Eur. Urol. Suppl. 2017. -N16. –V.5. –P.2192.

[29] Panagiotou A., Gaiao S., Cruz D.N. Extracorporeal therapies in sepsis // J. Intensive Care Med. 2013. –N5.

–V.28. –P.281-295.

[30] Rosenberg S., Restifo N., Yang J., Morgan R., Dudley M. Adoptive cell transfer: a clinical path to effective cancer immunotherapy // Nature Reviews Cancer. –2008. –N8. –P.299–308.

[31] Sakuraba A., Naganuma M., Hibi T., Ishii H. Intensive therapy of granulocyte and monocyte absorption apheresis induces rapid remission in patients with ulcerative colitis // Gastroenterology. -2003. -N4. –V.124. -P. 1379.

[32] Yoshioka S., Fujiwara H., Nakayama T.I.

Downloads

Published

31.07.2020

How to Cite

N. Tillyashaikhov, M., V. Kamishov, S., & A. Tillyashaikhova, M. (2020). Methods of Extracorporeal Immunopharmacotherapy: From General Medical Clinical Practice to Oncologic Practice (Literature Review). International Journal of Psychosocial Rehabilitation, 24(5), 4805-4812. https://doi.org/10.61841/abz07d50